货号 | MAB814-500 |
别名 | Fibroblast interferon; IFBIFNB; IFF; IFNB1; IFN-beta; interferon beta; interferon, beta 1, fibroblast; MGC96956 | 全称 | Interferon beta |
反应种属 | Human |
应用 | Western Blot(1 µg/mL) |
目标/特异性 | Detects human IFN-beta in Western blots. In Western blots, this antibody does not cross-react with recombinant human IFN‑ alpha. |
使用方法 | Western Blot: 1 µg/mL Neutralization: Measured by its ability to neutralize IFN‑ beta inhibition of EMCV-induced cytopathy in the HeLa human cervical epithelial carcinoma cell line. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The Neutralization Dose (ND50) is typically 7-21 µg/mL in the presence of 50 pg/mL Recombinant Human IFN‑ beta. |
来源 | Monoclonal Mouse IgG1 Clone # 76703 |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 3456 (Human); 15977 (Mouse); 24481 (Rat) |
应用文献 | |
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. | |
纯化方式 | Protein A or G purified from ascites |
免疫原 | E. coli-derived recombinant human IFN-beta Met22-Asn187 Accession # P01574 |
内毒素水平 | <0.10 EU per 1 μg of the antibody by the LAL method. |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitute at 0.5 mg/mL in sterile PBS. |
背景 | Interferon beta (IFN-beta ) is synthesized and secreted by fibroblasts and many other cell types in response to pathogens. IFN-beta binding to type I interferon receptors induces the upregulation of IRF-7 and activation of Rnase L. IRF-7 can exert a positive feedback on IFN-beta production. RNase L cleaves both viral and cellular single stranded mRNA, thereby limiting viral replication and dissemination. |
运输条件 | Blue Ice |
存放说明 | -20℃ |
参考文献 |
|
IFN‑ beta Inhibition of EMCV-induced Cytopathy and Neutralization by Human IFN‑ beta Antibody. Recombinant Human IFN‑ beta (Catalog # 8499-IF) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HeLa human cervical epithelial carcinoma cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Human IFN‑ beta (50 pg/mL) is neutralized (green line) by increasing concentrations of Human IFN‑ beta Monoclonal Antibody (Catalog # MAB814). The ND50 is typically 7-21 µg/mL. |